nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Mitoxantrone—lymphatic system cancer	0.253	0.303	CbGbCtD
Fluorescein—ABCB11—Vincristine—lymphatic system cancer	0.245	0.294	CbGbCtD
Fluorescein—ABCC1—Vincristine—lymphatic system cancer	0.174	0.209	CbGbCtD
Fluorescein—ABCC1—Methotrexate—lymphatic system cancer	0.105	0.126	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—lymphatic system cancer	0.057	0.0684	CbGbCtD
Fluorescein—Urine color abnormal—Mitoxantrone—lymphatic system cancer	0.00602	0.0361	CcSEcCtD
Fluorescein—Vasospasm—Carmustine—lymphatic system cancer	0.00446	0.0268	CcSEcCtD
Fluorescein—Chromaturia—Mitoxantrone—lymphatic system cancer	0.00397	0.0238	CcSEcCtD
Fluorescein—Hypoxia—Fludarabine—lymphatic system cancer	0.00375	0.0225	CcSEcCtD
Fluorescein—Pallor—Teniposide—lymphatic system cancer	0.00327	0.0196	CcSEcCtD
Fluorescein—Extravasation—Teniposide—lymphatic system cancer	0.00311	0.0186	CcSEcCtD
Fluorescein—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.00308	0.0185	CcSEcCtD
Fluorescein—Neoplasm—Teniposide—lymphatic system cancer	0.00245	0.0147	CcSEcCtD
Fluorescein—Respiratory failure—Fludarabine—lymphatic system cancer	0.00243	0.0145	CcSEcCtD
Fluorescein—Aphasia—Carmustine—lymphatic system cancer	0.00235	0.0141	CcSEcCtD
Fluorescein—Extravasation—Bleomycin—lymphatic system cancer	0.002	0.012	CcSEcCtD
Fluorescein—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00176	0.0106	CcSEcCtD
Fluorescein—Extravasation—Carmustine—lymphatic system cancer	0.00175	0.0105	CcSEcCtD
Fluorescein—Bronchospasm—Teniposide—lymphatic system cancer	0.00167	0.01	CcSEcCtD
Fluorescein—Extravasation—Vincristine—lymphatic system cancer	0.00167	0.01	CcSEcCtD
Fluorescein—Extravasation—Mitoxantrone—lymphatic system cancer	0.00162	0.00974	CcSEcCtD
Fluorescein—Respiratory failure—Vincristine—lymphatic system cancer	0.00148	0.00889	CcSEcCtD
Fluorescein—Angina pectoris—Fludarabine—lymphatic system cancer	0.00146	0.00873	CcSEcCtD
Fluorescein—Neoplasm—Carmustine—lymphatic system cancer	0.00138	0.00827	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00136	0.00815	CcSEcCtD
Fluorescein—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00131	0.00787	CcSEcCtD
Fluorescein—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00129	0.00776	CcSEcCtD
Fluorescein—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00128	0.00767	CcSEcCtD
Fluorescein—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00127	0.00764	CcSEcCtD
Fluorescein—Chills—Teniposide—lymphatic system cancer	0.00122	0.00732	CcSEcCtD
Fluorescein—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00119	0.00714	CcSEcCtD
Fluorescein—Hypoxia—Methotrexate—lymphatic system cancer	0.00111	0.00667	CcSEcCtD
Fluorescein—Aphasia—Methotrexate—lymphatic system cancer	0.00109	0.00653	CcSEcCtD
Fluorescein—Bronchospasm—Bleomycin—lymphatic system cancer	0.00108	0.00646	CcSEcCtD
Fluorescein—Chills—Fludarabine—lymphatic system cancer	0.00107	0.00644	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00106	0.00637	CcSEcCtD
Fluorescein—Hypertension—Teniposide—lymphatic system cancer	0.00102	0.00613	CcSEcCtD
Fluorescein—Chest pain—Teniposide—lymphatic system cancer	0.00101	0.00605	CcSEcCtD
Fluorescein—Cardiac arrest—Vincristine—lymphatic system cancer	0.001	0.00602	CcSEcCtD
Fluorescein—Oedema—Teniposide—lymphatic system cancer	0.000967	0.0058	CcSEcCtD
Fluorescein—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000967	0.00579	CcSEcCtD
Fluorescein—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000966	0.00579	CcSEcCtD
Fluorescein—Tachycardia—Teniposide—lymphatic system cancer	0.000944	0.00566	CcSEcCtD
Fluorescein—Malaise—Fludarabine—lymphatic system cancer	0.000939	0.00563	CcSEcCtD
Fluorescein—Hyperhidrosis—Teniposide—lymphatic system cancer	0.000935	0.00561	CcSEcCtD
Fluorescein—Pruritus—Mechlorethamine—lymphatic system cancer	0.000928	0.00556	CcSEcCtD
Fluorescein—Cough—Fludarabine—lymphatic system cancer	0.000909	0.00545	CcSEcCtD
Fluorescein—Hypotension—Teniposide—lymphatic system cancer	0.000904	0.00542	CcSEcCtD
Fluorescein—Convulsion—Fludarabine—lymphatic system cancer	0.000902	0.00541	CcSEcCtD
Fluorescein—Discomfort—Fludarabine—lymphatic system cancer	0.000876	0.00525	CcSEcCtD
Fluorescein—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000873	0.00523	CcSEcCtD
Fluorescein—Dyspnoea—Teniposide—lymphatic system cancer	0.000862	0.00517	CcSEcCtD
Fluorescein—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00085	0.0051	CcSEcCtD
Fluorescein—Oedema—Fludarabine—lymphatic system cancer	0.00085	0.0051	CcSEcCtD
Fluorescein—Vomiting—Mechlorethamine—lymphatic system cancer	0.000834	0.005	CcSEcCtD
Fluorescein—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000834	0.005	CcSEcCtD
Fluorescein—Rash—Mechlorethamine—lymphatic system cancer	0.000827	0.00496	CcSEcCtD
Fluorescein—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000826	0.00495	CcSEcCtD
Fluorescein—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000822	0.00493	CcSEcCtD
Fluorescein—Extravasation—Methotrexate—lymphatic system cancer	0.000809	0.00485	CcSEcCtD
Fluorescein—Feeling abnormal—Teniposide—lymphatic system cancer	0.000797	0.00478	CcSEcCtD
Fluorescein—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000791	0.00474	CcSEcCtD
Fluorescein—Chills—Bleomycin—lymphatic system cancer	0.000787	0.00472	CcSEcCtD
Fluorescein—Skin discolouration—Methotrexate—lymphatic system cancer	0.000782	0.00469	CcSEcCtD
Fluorescein—Nausea—Mechlorethamine—lymphatic system cancer	0.000779	0.00467	CcSEcCtD
Fluorescein—Urticaria—Teniposide—lymphatic system cancer	0.000768	0.00461	CcSEcCtD
Fluorescein—Abdominal pain—Teniposide—lymphatic system cancer	0.000765	0.00458	CcSEcCtD
Fluorescein—Erythema—Bleomycin—lymphatic system cancer	0.000764	0.00458	CcSEcCtD
Fluorescein—Paraesthesia—Fludarabine—lymphatic system cancer	0.000763	0.00458	CcSEcCtD
Fluorescein—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000762	0.00457	CcSEcCtD
Fluorescein—Dyspnoea—Fludarabine—lymphatic system cancer	0.000758	0.00454	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000734	0.0044	CcSEcCtD
Fluorescein—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000727	0.00436	CcSEcCtD
Fluorescein—Pain—Fludarabine—lymphatic system cancer	0.000727	0.00436	CcSEcCtD
Fluorescein—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000725	0.00434	CcSEcCtD
Fluorescein—Respiratory failure—Methotrexate—lymphatic system cancer	0.000719	0.00431	CcSEcCtD
Fluorescein—Hypersensitivity—Teniposide—lymphatic system cancer	0.000713	0.00427	CcSEcCtD
Fluorescein—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000709	0.00425	CcSEcCtD
Fluorescein—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0007	0.0042	CcSEcCtD
Fluorescein—Asthenia—Teniposide—lymphatic system cancer	0.000694	0.00416	CcSEcCtD
Fluorescein—Malaise—Bleomycin—lymphatic system cancer	0.000689	0.00413	CcSEcCtD
Fluorescein—Pruritus—Teniposide—lymphatic system cancer	0.000684	0.0041	CcSEcCtD
Fluorescein—Cardiac disorder—Vincristine—lymphatic system cancer	0.000678	0.00407	CcSEcCtD
Fluorescein—Erythema—Carmustine—lymphatic system cancer	0.000667	0.004	CcSEcCtD
Fluorescein—Cough—Bleomycin—lymphatic system cancer	0.000666	0.004	CcSEcCtD
Fluorescein—Angiopathy—Vincristine—lymphatic system cancer	0.000663	0.00398	CcSEcCtD
Fluorescein—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000659	0.00395	CcSEcCtD
Fluorescein—Chest pain—Bleomycin—lymphatic system cancer	0.00065	0.0039	CcSEcCtD
Fluorescein—Discomfort—Bleomycin—lymphatic system cancer	0.000642	0.00385	CcSEcCtD
Fluorescein—Chills—Mitoxantrone—lymphatic system cancer	0.000639	0.00383	CcSEcCtD
Fluorescein—Neoplasm—Methotrexate—lymphatic system cancer	0.000639	0.00383	CcSEcCtD
Fluorescein—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000629	0.00377	CcSEcCtD
Fluorescein—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000626	0.00375	CcSEcCtD
Fluorescein—Tremor—Carmustine—lymphatic system cancer	0.000624	0.00374	CcSEcCtD
Fluorescein—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000623	0.00374	CcSEcCtD
Fluorescein—Oedema—Bleomycin—lymphatic system cancer	0.000623	0.00374	CcSEcCtD
Fluorescein—Erythema—Mitoxantrone—lymphatic system cancer	0.00062	0.00372	CcSEcCtD
Fluorescein—Vomiting—Teniposide—lymphatic system cancer	0.000615	0.00369	CcSEcCtD
Fluorescein—Asthenia—Fludarabine—lymphatic system cancer	0.00061	0.00366	CcSEcCtD
Fluorescein—Rash—Teniposide—lymphatic system cancer	0.00061	0.00366	CcSEcCtD
Fluorescein—Dermatitis—Teniposide—lymphatic system cancer	0.000609	0.00365	CcSEcCtD
Fluorescein—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000607	0.00364	CcSEcCtD
Fluorescein—Headache—Teniposide—lymphatic system cancer	0.000606	0.00363	CcSEcCtD
Fluorescein—Pruritus—Fludarabine—lymphatic system cancer	0.000601	0.00361	CcSEcCtD
Fluorescein—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000592	0.00355	CcSEcCtD
Fluorescein—Hypotension—Bleomycin—lymphatic system cancer	0.000582	0.00349	CcSEcCtD
Fluorescein—Convulsion—Carmustine—lymphatic system cancer	0.000578	0.00346	CcSEcCtD
Fluorescein—Hypertension—Carmustine—lymphatic system cancer	0.000575	0.00345	CcSEcCtD
Fluorescein—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000575	0.00345	CcSEcCtD
Fluorescein—Nausea—Teniposide—lymphatic system cancer	0.000574	0.00344	CcSEcCtD
Fluorescein—Chest pain—Carmustine—lymphatic system cancer	0.000567	0.0034	CcSEcCtD
Fluorescein—Paraesthesia—Bleomycin—lymphatic system cancer	0.00056	0.00336	CcSEcCtD
Fluorescein—Malaise—Mitoxantrone—lymphatic system cancer	0.000559	0.00335	CcSEcCtD
Fluorescein—Dyspnoea—Bleomycin—lymphatic system cancer	0.000556	0.00333	CcSEcCtD
Fluorescein—Convulsion—Vincristine—lymphatic system cancer	0.000551	0.00331	CcSEcCtD
Fluorescein—Hypertension—Vincristine—lymphatic system cancer	0.000549	0.00329	CcSEcCtD
Fluorescein—Oedema—Carmustine—lymphatic system cancer	0.000544	0.00326	CcSEcCtD
Fluorescein—Cough—Mitoxantrone—lymphatic system cancer	0.000541	0.00324	CcSEcCtD
Fluorescein—Vomiting—Fludarabine—lymphatic system cancer	0.00054	0.00324	CcSEcCtD
Fluorescein—Convulsion—Mitoxantrone—lymphatic system cancer	0.000537	0.00322	CcSEcCtD
Fluorescein—Rash—Fludarabine—lymphatic system cancer	0.000536	0.00321	CcSEcCtD
Fluorescein—Dermatitis—Fludarabine—lymphatic system cancer	0.000535	0.00321	CcSEcCtD
Fluorescein—Hypertension—Mitoxantrone—lymphatic system cancer	0.000535	0.00321	CcSEcCtD
Fluorescein—Pain—Bleomycin—lymphatic system cancer	0.000533	0.0032	CcSEcCtD
Fluorescein—Headache—Fludarabine—lymphatic system cancer	0.000532	0.00319	CcSEcCtD
Fluorescein—Tachycardia—Carmustine—lymphatic system cancer	0.000531	0.00318	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00053	0.00318	CcSEcCtD
Fluorescein—Chest pain—Mitoxantrone—lymphatic system cancer	0.000528	0.00316	CcSEcCtD
Fluorescein—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000523	0.00314	CcSEcCtD
Fluorescein—Discomfort—Mitoxantrone—lymphatic system cancer	0.000521	0.00313	CcSEcCtD
Fluorescein—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000519	0.00311	CcSEcCtD
Fluorescein—Oedema—Vincristine—lymphatic system cancer	0.000519	0.00311	CcSEcCtD
Fluorescein—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000514	0.00308	CcSEcCtD
Fluorescein—Nervous system disorder—Vincristine—lymphatic system cancer	0.000509	0.00305	CcSEcCtD
Fluorescein—Hypotension—Carmustine—lymphatic system cancer	0.000508	0.00305	CcSEcCtD
Fluorescein—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000506	0.00303	CcSEcCtD
Fluorescein—Oedema—Mitoxantrone—lymphatic system cancer	0.000506	0.00303	CcSEcCtD
Fluorescein—Nausea—Fludarabine—lymphatic system cancer	0.000505	0.00303	CcSEcCtD
Fluorescein—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000502	0.00301	CcSEcCtD
Fluorescein—Shock—Mitoxantrone—lymphatic system cancer	0.000498	0.00298	CcSEcCtD
Fluorescein—Urticaria—Bleomycin—lymphatic system cancer	0.000495	0.00297	CcSEcCtD
Fluorescein—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000494	0.00296	CcSEcCtD
Fluorescein—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000491	0.00295	CcSEcCtD
Fluorescein—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000489	0.00293	CcSEcCtD
Fluorescein—Paraesthesia—Carmustine—lymphatic system cancer	0.000488	0.00293	CcSEcCtD
Fluorescein—Hypotension—Vincristine—lymphatic system cancer	0.000485	0.00291	CcSEcCtD
Fluorescein—Dyspnoea—Carmustine—lymphatic system cancer	0.000485	0.00291	CcSEcCtD
Fluorescein—Hypotension—Mitoxantrone—lymphatic system cancer	0.000473	0.00283	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00047	0.00282	CcSEcCtD
Fluorescein—Paraesthesia—Vincristine—lymphatic system cancer	0.000466	0.0028	CcSEcCtD
Fluorescein—Pain—Carmustine—lymphatic system cancer	0.000465	0.00279	CcSEcCtD
Fluorescein—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000459	0.00275	CcSEcCtD
Fluorescein—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000454	0.00272	CcSEcCtD
Fluorescein—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000451	0.0027	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000448	0.00269	CcSEcCtD
Fluorescein—Feeling abnormal—Carmustine—lymphatic system cancer	0.000448	0.00269	CcSEcCtD
Fluorescein—Asthenia—Bleomycin—lymphatic system cancer	0.000447	0.00268	CcSEcCtD
Fluorescein—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000445	0.00267	CcSEcCtD
Fluorescein—Pain—Vincristine—lymphatic system cancer	0.000444	0.00266	CcSEcCtD
Fluorescein—Asthma—Methotrexate—lymphatic system cancer	0.000443	0.00266	CcSEcCtD
Fluorescein—Pruritus—Bleomycin—lymphatic system cancer	0.000441	0.00264	CcSEcCtD
Fluorescein—Pain—Mitoxantrone—lymphatic system cancer	0.000432	0.00259	CcSEcCtD
Fluorescein—Abdominal pain—Carmustine—lymphatic system cancer	0.00043	0.00258	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000425	0.00255	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000425	0.00255	CcSEcCtD
Fluorescein—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000417	0.0025	CcSEcCtD
Fluorescein—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000414	0.00248	CcSEcCtD
Fluorescein—Abdominal pain—Vincristine—lymphatic system cancer	0.000411	0.00246	CcSEcCtD
Fluorescein—Urticaria—Mitoxantrone—lymphatic system cancer	0.000402	0.00241	CcSEcCtD
Fluorescein—Hypersensitivity—Carmustine—lymphatic system cancer	0.000401	0.0024	CcSEcCtD
Fluorescein—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0004	0.0024	CcSEcCtD
Fluorescein—Vomiting—Bleomycin—lymphatic system cancer	0.000396	0.00238	CcSEcCtD
Fluorescein—Rash—Bleomycin—lymphatic system cancer	0.000393	0.00236	CcSEcCtD
Fluorescein—Dermatitis—Bleomycin—lymphatic system cancer	0.000393	0.00235	CcSEcCtD
Fluorescein—Asthenia—Carmustine—lymphatic system cancer	0.00039	0.00234	CcSEcCtD
Fluorescein—Hypersensitivity—Vincristine—lymphatic system cancer	0.000383	0.00229	CcSEcCtD
Fluorescein—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000373	0.00223	CcSEcCtD
Fluorescein—Asthenia—Vincristine—lymphatic system cancer	0.000373	0.00223	CcSEcCtD
Fluorescein—Nausea—Bleomycin—lymphatic system cancer	0.00037	0.00222	CcSEcCtD
Fluorescein—Asthenia—Mitoxantrone—lymphatic system cancer	0.000363	0.00218	CcSEcCtD
Fluorescein—Dizziness—Carmustine—lymphatic system cancer	0.00036	0.00216	CcSEcCtD
Fluorescein—Vomiting—Carmustine—lymphatic system cancer	0.000346	0.00207	CcSEcCtD
Fluorescein—Dizziness—Vincristine—lymphatic system cancer	0.000343	0.00206	CcSEcCtD
Fluorescein—Rash—Carmustine—lymphatic system cancer	0.000343	0.00206	CcSEcCtD
Fluorescein—Dermatitis—Carmustine—lymphatic system cancer	0.000343	0.00205	CcSEcCtD
Fluorescein—Headache—Carmustine—lymphatic system cancer	0.000341	0.00204	CcSEcCtD
Fluorescein—Vomiting—Vincristine—lymphatic system cancer	0.00033	0.00198	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000329	0.00197	CcSEcCtD
Fluorescein—Rash—Vincristine—lymphatic system cancer	0.000327	0.00196	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—lymphatic system cancer	0.000327	0.00196	CcSEcCtD
Fluorescein—Headache—Vincristine—lymphatic system cancer	0.000325	0.00195	CcSEcCtD
Fluorescein—Nausea—Carmustine—lymphatic system cancer	0.000323	0.00194	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—lymphatic system cancer	0.000322	0.00193	CcSEcCtD
Fluorescein—Vomiting—Mitoxantrone—lymphatic system cancer	0.000322	0.00193	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—lymphatic system cancer	0.00032	0.00192	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00032	0.00192	CcSEcCtD
Fluorescein—Rash—Mitoxantrone—lymphatic system cancer	0.000319	0.00191	CcSEcCtD
Fluorescein—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000319	0.00191	CcSEcCtD
Fluorescein—Chills—Methotrexate—lymphatic system cancer	0.000318	0.00191	CcSEcCtD
Fluorescein—Headache—Mitoxantrone—lymphatic system cancer	0.000317	0.0019	CcSEcCtD
Fluorescein—Erythema—Methotrexate—lymphatic system cancer	0.000309	0.00185	CcSEcCtD
Fluorescein—Nausea—Vincristine—lymphatic system cancer	0.000308	0.00185	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—lymphatic system cancer	0.000302	0.00181	CcSEcCtD
Fluorescein—Nausea—Mitoxantrone—lymphatic system cancer	0.0003	0.0018	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000286	0.00172	CcSEcCtD
Fluorescein—Malaise—Methotrexate—lymphatic system cancer	0.000278	0.00167	CcSEcCtD
Fluorescein—Cough—Methotrexate—lymphatic system cancer	0.000269	0.00162	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—lymphatic system cancer	0.000268	0.0016	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—lymphatic system cancer	0.000263	0.00158	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000261	0.00157	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—lymphatic system cancer	0.00026	0.00156	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000252	0.00151	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000247	0.00148	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—lymphatic system cancer	0.000245	0.00147	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000244	0.00146	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—lymphatic system cancer	0.000235	0.00141	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—lymphatic system cancer	0.000226	0.00136	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—lymphatic system cancer	0.000225	0.00135	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000218	0.0013	CcSEcCtD
Fluorescein—Pain—Methotrexate—lymphatic system cancer	0.000215	0.00129	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000208	0.00124	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000206	0.00124	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—lymphatic system cancer	0.0002	0.0012	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—lymphatic system cancer	0.000199	0.00119	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000186	0.00111	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—lymphatic system cancer	0.000181	0.00108	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—lymphatic system cancer	0.000178	0.00107	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—lymphatic system cancer	0.000167	0.000999	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—lymphatic system cancer	0.00016	0.000961	CcSEcCtD
Fluorescein—Rash—Methotrexate—lymphatic system cancer	0.000159	0.000953	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—lymphatic system cancer	0.000159	0.000952	CcSEcCtD
Fluorescein—Headache—Methotrexate—lymphatic system cancer	0.000158	0.000946	CcSEcCtD
Fluorescein—Nausea—Methotrexate—lymphatic system cancer	0.00015	0.000897	CcSEcCtD
